全球病毒学检测市场 2023

$1,950.00

产品代码: GB04957I 行业: 地区:
市场概况

The Global Virology Testing Market is poised for growth, 预计美元增幅 12.48 十亿 2022 兑美元 13.65 十亿 2029, reflecting a modest compound annual growth rate (复合年增长率) 的 1.2% during the period from 2023 到 2029. Virology testing encompasses a range of diagnostic techniques employed to identify viruses, including cell culture, antibody detection, antigen detection, nucleic acid detection, gene sequencing, and hemagglutination assays.

The COVID-19 pandemic has significantly propelled market growth, primarily driven by the escalating number of cases and the emergence of new viral strains. In response, companies have introduced diagnostic tests and kits, expanding their product portfolios to meet the growing demand. 此外, collaborations between industry players and governments have played a pivotal role in driving market expansion, fostering innovation, and enhancing testing capabilities.

The prevalence of viral diseases, coupled with the continuous emergence of new pathogens, is expected to be a key driver for market growth. 此外, the approval of new virology testing products by regulatory authorities will further contribute to market expansion, providing healthcare professionals with advanced tools for accurate and timely diagnosis.

然而, it is important to note that stringent regulations governing virology testing may pose challenges for market players. Compliance with these regulations, including quality control measures and adherence to safety standards, requires significant investments and resources.

市场细分

The market is segmented based on component, diagnostic technique, 最终用户, 和地理.

Segmentation by Component
仪器
Assay Kits and Consumables

Segmentation by Diagnostic Technique
Molecular Diagnostics MethodPCR-based methods, NGS-based methods
Immunoassay-based Method
Mass Spectroscopy-based Method
其他的

Segmentation by End User
Hospitals and Clinics
Diagnostic Laboratories
其他的

按地理位置细分
北美 – 美国, 加拿大, 墨西哥
欧洲 – 英国, 德国, 法国, 意大利, 西班牙, and Rest of Europe
亚太 – 中国, 日本, 印度, 澳大利亚, 韩国, and Rest of Asia-Pacific
拉美 – 巴西, 阿根廷, and Rest of Latin America
中东和非洲 – GCC, 南非, and Rest of Middle East and Africa

The PCR-based molecular diagnostic methods segment is expected to gain a significant market share. PCR methods are widely used for pathogen detection, including viruses, and have improved diagnostic testing by reducing time and increasing accuracy. The COVID-19 pandemic has further boosted the segment’s growth, with RT-PCR being the preferred diagnostic method for COVID-19. Pharmaceutical and biotech companies are actively researching new molecules for COVID-19 treatment. Initiatives such as the launch of “”ViraGen”” in India and the development of a portable PCR molecular assay for monkeypox virus detection by Anitoa indicate the segment’s growth potential.

The regional market has grown due to advanced diagnostic methods, healthcare spending, favorable policies, and advanced laboratories. The United States’ 右&D activities and viral infection cases, like influenza and HIV, have fueled demand for testing, leading to market growth. The virology testing market in the region is expected to continue growing.

竞争格局

The virology testing market is fragmented and has many major players. 现在, a small number of these major players dominate the industry and hold significant market share. Some of the companies operating in this market include Abbott Laboratories, bioMerieux S.A., Bio-Rad 实验室公司, Cepheid Inc., DiaSorin S.p.A., F. 罗氏霍夫曼公司, Fujirebio Diagnostics Inc., 豪洛捷公司, 凯杰公司, Siemens Healthineers AG, 赛默飞世尔科技公司, 三一生物科技有限公司, Vircell S.L., 和别的.

最新行业发展

QuantuMDx Group Limited announced the launch of its Q-POC SARS-CoV-2, Flu A/B & RSV Assay in May 2022. This respiratory panel test is compatible with the Q-POC platform, providing rapid point-of-care testing capabilities in clinical and non-clinical settings.

在一月 2022, InTec introduced the AQ+ Covid-19 Ag Rapid Test, an ultra-sensitive SARS-CoV-2 Rapid Antigen Test for professional use. This test enables healthcare professionals or laypersons to quickly and conveniently detect Covid-19, contributing to the ongoing efforts against the pandemic.

Why Buy This Report?

Get a detailed picture of the Global Virology Testing Market
Identify segments/areas to invest in over the forecast period in the Global Virology Testing Market
了解竞争环境, 市场的领先参与者
Excel 格式的跨场景分析易用性的市场预估
三个月的战略咨询和研究支持
为单用户许可证提供打印验证

全球病毒学检测市场 2023

对这份报告感兴趣? 立即获取免费样品!
全球病毒学检测市场 2023 - 报告范围
报告属性

细节

市场规模 (2022)

美元 12.48 十亿

基准年

2022

预测年份

2023-2029

复合年增长率 (2023-2029)

1.24%

页数

23

细分依据

Component, Diagnostic Technique, 终端用户, 地理

覆盖地区

全球的

行业参与者

雅培实验室, bioMerieux S.A., Bio-Rad 实验室公司, Cepheid Inc., DiaSorin S.p.A., F. 罗氏霍夫曼公司, Fujirebio Diagnostics Inc., 豪洛捷公司, 凯杰公司, Siemens Healthineers AG, 赛默飞世尔科技公司, 三一生物科技有限公司, Vircell S.L.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - 全球病毒学检测市场 2023

请填写我们的表格,我们会尽快回复您.